We are Sorry, This Page doesn't Exist
Trovagene presents final results from Phase 1b onvansertib study at ASH
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Portola presents interim results from Phase 2a study of cerdulatinib
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Biogen (BIIB) Presents Aducanumab Phase 3 Topline Results - Slideshow
Biogen (BIIB) Presents Aducanumab Phase 3 Topline Results - Slideshow.....»»
Emergent BioSolutions presents immunogenicity results from Phase 2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Provectus presents updated results from Phase 1B trial of PV-10, KEYTRUDA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Nektar presents updated results from Phase 1a study of NKTR-358
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aduro Biotech presents results from phase 1 study of anti-CD27 agonist
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Corvus presents updated data from CPI-006 Phase 1/1b trial at SITC meeting
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca presents results from Phase III Olympus, Rockies trials
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Can-Fite BioPharma announces results from Namodenoson End-of-Phase 2 meeting
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Dermira presents primary results from phase 2b lebrikizumab study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Dermira presents primary results from phase 2b lebrikizumab study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Zogenix presents top-line results from Phase 2 RETRO study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Summit Therapeutics presents results from Phase 2 trial of ridinilazole
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca, Merck presents results from Phase 3 PROfound trial of LYNPARZA
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Hutchison China MediTech presents results from Phase III stufe of surufatinib
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AstraZeneca presents OS results from Phase III FLAURA trial of TAGRISSO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Clearside Biomedical presents results from MAGNOLIA Phase 3 extension study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Atara Biotherapeutics presents results from ATA188 Phase 1 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Axsome Therapeutics presents AXS-07 Phase 1 trial results at Congress of the IHC
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»